Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$405M |
| 2 |
iShares Global Infrastructure ETF
IGF
|
+$193M |
| 3 |
Tesla
TSLA
|
+$193M |
| 4 |
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
|
+$160M |
| 5 |
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$588M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$427M |
| 3 |
Microsoft
MSFT
|
+$323M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$203M |
| 5 |
Chevron
CVX
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.79% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.35% |
| 5 | Industrials | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMIC
3251
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $1.2M | ﹤0.01% |
16,050
+2,368
| +17% | +$247K |
|
3252
First Watch Restaurant Group
FWRG
$800M
| $1.2M | ﹤0.01% |
82,708
-613
| -0.7% | -$9.95K |
|
3253
VanEck Morningstar Wide Moat ETF
MOAT
$12.5B
| $1.2M | ﹤0.01% |
19,913
-715
| -3% | -$48.1K |
|
3254
Outlook Therapeutics
OTLK
$166M
| $1.19M | ﹤0.01% |
48,817
+72
| +0.1% | +$1.67K |
|
3255
Stevanato
STVN
$5.88B
| $1.19M | ﹤0.01% |
+70,228
| New | +$1.18M |
|
|
KRON
3256
DELISTED
Kronos Bio
KRON
| $1.19M | ﹤0.01% |
353,860
-1,980
| -0.6% | -$8.94K |
|
|
STLN
3257
Starling Oncology, Inc. Common Stock
STLN
$638M
| $1.18M | ﹤0.01% |
255,349
+111,428
| +77% | +$655K |
|
3258
Superior Group of Companies
SGC
$210M
| $1.18M | ﹤0.01% |
132,907
+484
| +0.4% | +$6.96K |
|
3259
CleanSpark
CLSK
$2.96B
| $1.18M | ﹤0.01% |
369,609
+36,316
| +11% | +$157K |
|
3260
Pliant Therapeutics
PLRX
$66.9M
| $1.18M | ﹤0.01% |
56,301
+18,540
| +49% | +$355K |
|
|
ATCX
3261
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $1.17M | ﹤0.01% |
175,961
+26,620
| +18% | +$191K |
|
3262
Bakkt Inc
BKKT
$331M
| $1.17M | ﹤0.01% |
20,453
+1,864
| +10% | +$125K |
|
|
NTCO
3263
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
| $1.17M | ﹤0.01% |
213,323
+47,995
| +29% | +$281K |
|
3264
USCB Financial Holdings
USCB
$418M
| $1.16M | ﹤0.01% |
88,830
+11,076
| +14% | +$142K |
|
|
GTHX
3265
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.16M | ﹤0.01% |
92,975
+1,084
| +1% | +$12.4K |
|
3266
Atlanticus Holdings
ATLC
$1.47B
| $1.16M | ﹤0.01% |
44,178
-881
| -2% | -$30.3K |
|
3267
Safe Bulkers
SB
$781M
| $1.15M | ﹤0.01% |
465,801
-15,572
| -3% | -$52.7K |
|
|
VIEW
3268
DELISTED
View, Inc. Class A Common Stock
VIEW
| $1.15M | ﹤0.01% |
14,272
+137
| +1% | +$15.6K |
|
3269
Dr. Reddy's Laboratories
RDY
$10.3B
| $1.14M | ﹤0.01% |
108,910
-3,475
| -3% | -$37K |
|
3270
HF Foods Group
HFFG
$97.6M
| $1.14M | ﹤0.01% |
293,296
-8,728
| -3% | -$43.3K |
|
3271
Tilray
TLRY
$640M
| $1.14M | ﹤0.01% |
41,294
+3,324
| +9% | +$117K |
|
|
MAPS
3272
DELISTED
WM TECHNOLOGY INC A
MAPS
| $1.13M | ﹤0.01% |
704,330
+80,168
| +13% | +$228K |
|
3273
1stdibs.com
DIBS
$163M
| $1.13M | ﹤0.01% |
180,230
+16,488
| +10% | +$107K |
|
3274
Blue Owl Capital
OBDC
$5.87B
| $1.13M | ﹤0.01% |
109,019
+11,188
| +11% | +$142K |
|
|
STRS
3275
DELISTED
STRATUS PPTYS INC
STRS
| $1.13M | ﹤0.01% |
48,532
-5,062
| -9% | -$160K |
|
Similar funds
Northern Trust's Q3 2022 Portfolio in Review
As of Q3 2022, Northern Trust held 4,838 positions worth $438B, down 6.2% from $467B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 4.4%. Northern Trust opened 89 new positions and exited 125, leaving the 4,838-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Northern Trust's largest Q3 2022 buy was Haleon: 2,056,623 shares worth $12.5M.
- Northern Trust added most to iShares MSCI Emerging Markets ETF in Q3 2022, an estimated $405M increase.
- Northern Trust's biggest Q3 2022 reduction was Apple, cutting an estimated $588M.
- Northern Trust fully exited CDK Global, Inc. in Q3 2022, selling an estimated $95.8M.
- Northern Trust's ten largest holdings make up 21% of its $438B portfolio in Q3 2022.
- Northern Trust opened 89 new positions and closed 125 in Q3 2022.
- Northern Trust's portfolio value fell 6.2% quarter-over-quarter to $438B.
Based on Northern Trust's 13F filing for Q3 2022, filed 14 Nov 2022.